Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus.

Abstract

Bone mineral density (BMD) at the lumbar spine, quantified by dual energy X-ray absorptiometry, and biochemical bone remodeling markers (serum alkaline phosphatase, osteocalcin, tartrate-resistant acid phosphatase and urinary hydroxyproline) have been studied in 94 patients with diabetes mellitus aged 18-62 years. BMD was normal (1.13 +/- 0.02 g/cm2 in… (More)

Topics

Cite this paper

@article{Olmos1994BoneDA, title={Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus.}, author={J. M. Olmos and Jos{\'e}-Luis P{\'e}rez-Castrill{\'o}n and Monique T Garcia and Juliana Cabrera Garrido and J. A. Amado and Jes{\'u}s Gonz{\'a}lez-Mac{\'i}as}, journal={Bone and mineral}, year={1994}, volume={26 1}, pages={1-8} }